vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and QUALYS, INC. (QLYS). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $175.3M, roughly 1.5× QUALYS, INC.). QUALYS, INC. runs the higher net margin — 30.3% vs 0.7%, a 29.6% gap on every dollar of revenue. On growth, QUALYS, INC. posted the faster year-over-year revenue change (10.1% vs -16.5%). QUALYS, INC. produced more free cash flow last quarter ($74.9M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Qualys, Inc. is an American technology firm based in Foster City, California, specializing in cloud security, compliance and related services.
HCM vs QLYS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $175.3M |
| Net Profit | $2.0M | $53.1M |
| Gross Margin | 37.7% | 83.4% |
| Operating Margin | -13.2% | 33.6% |
| Net Margin | 0.7% | 30.3% |
| Revenue YoY | -16.5% | 10.1% |
| Net Profit YoY | -83.6% | 20.9% |
| EPS (diluted) | $0.00 | $1.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $175.3M | ||
| Q3 25 | — | $169.9M | ||
| Q2 25 | $277.7M | $164.1M | ||
| Q1 25 | $324.5M | $159.9M | ||
| Q4 24 | — | $159.2M | ||
| Q3 24 | — | $153.9M | ||
| Q2 24 | $305.7M | $148.7M | ||
| Q1 24 | — | $145.8M |
| Q4 25 | $2.0M | $53.1M | ||
| Q3 25 | — | $50.3M | ||
| Q2 25 | $455.0M | $47.3M | ||
| Q1 25 | $11.9M | $47.5M | ||
| Q4 24 | — | $44.0M | ||
| Q3 24 | — | $46.2M | ||
| Q2 24 | $25.8M | $43.8M | ||
| Q1 24 | — | $39.7M |
| Q4 25 | 37.7% | 83.4% | ||
| Q3 25 | — | 83.6% | ||
| Q2 25 | 0.1% | 82.4% | ||
| Q1 25 | 48.0% | 81.9% | ||
| Q4 24 | — | 81.8% | ||
| Q3 24 | — | 81.3% | ||
| Q2 24 | 41.1% | 82.2% | ||
| Q1 24 | — | 81.3% |
| Q4 25 | -13.2% | 33.6% | ||
| Q3 25 | — | 35.3% | ||
| Q2 25 | -1.3% | 31.3% | ||
| Q1 25 | -5.0% | 32.4% | ||
| Q4 24 | — | 31.0% | ||
| Q3 24 | — | 29.2% | ||
| Q2 24 | -9.0% | 32.3% | ||
| Q1 24 | — | 30.7% |
| Q4 25 | 0.7% | 30.3% | ||
| Q3 25 | — | 29.6% | ||
| Q2 25 | 163.8% | 28.8% | ||
| Q1 25 | 3.7% | 29.7% | ||
| Q4 24 | — | 27.6% | ||
| Q3 24 | — | 30.0% | ||
| Q2 24 | 8.4% | 29.4% | ||
| Q1 24 | — | 27.2% |
| Q4 25 | $0.00 | $1.47 | ||
| Q3 25 | — | $1.39 | ||
| Q2 25 | $0.52 | $1.29 | ||
| Q1 25 | $0.01 | $1.29 | ||
| Q4 24 | — | $1.19 | ||
| Q3 24 | — | $1.24 | ||
| Q2 24 | $0.03 | $1.17 | ||
| Q1 24 | — | $1.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $250.3M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $561.2M |
| Total Assets | $1.8B | $1.1B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $250.3M | ||
| Q3 25 | — | $225.3M | ||
| Q2 25 | $1.4B | $194.0M | ||
| Q1 25 | $836.1M | $290.7M | ||
| Q4 24 | — | $232.2M | ||
| Q3 24 | — | $235.4M | ||
| Q2 24 | $802.5M | $281.2M | ||
| Q1 24 | — | $273.8M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $561.2M | ||
| Q3 25 | — | $529.4M | ||
| Q2 25 | $1.2B | $508.2M | ||
| Q1 25 | $759.9M | $498.0M | ||
| Q4 24 | — | $477.1M | ||
| Q3 24 | — | $449.6M | ||
| Q2 24 | $740.1M | $427.8M | ||
| Q1 24 | — | $404.2M |
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $1.8B | $999.5M | ||
| Q1 25 | $1.3B | $996.5M | ||
| Q4 24 | — | $973.5M | ||
| Q3 24 | — | $908.3M | ||
| Q2 24 | $1.3B | $876.6M | ||
| Q1 24 | — | $861.8M |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $75.7M |
| Free Cash FlowOCF − Capex | $3.4M | $74.9M |
| FCF MarginFCF / Revenue | 1.2% | 42.8% |
| Capex IntensityCapex / Revenue | 1.8% | 0.4% |
| Cash ConversionOCF / Net Profit | 4.21× | 1.42× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $304.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $75.7M | ||
| Q3 25 | — | $90.4M | ||
| Q2 25 | $-72.9M | $33.8M | ||
| Q1 25 | $40.3M | $109.6M | ||
| Q4 24 | — | $47.7M | ||
| Q3 24 | — | $61.0M | ||
| Q2 24 | $-39.8M | $49.8M | ||
| Q1 24 | — | $85.5M |
| Q4 25 | $3.4M | $74.9M | ||
| Q3 25 | — | $89.5M | ||
| Q2 25 | $-82.2M | $32.4M | ||
| Q1 25 | $32.5M | $107.5M | ||
| Q4 24 | — | $41.9M | ||
| Q3 24 | — | $57.6M | ||
| Q2 24 | $-49.9M | $48.8M | ||
| Q1 24 | — | $83.5M |
| Q4 25 | 1.2% | 42.8% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | -29.6% | 19.8% | ||
| Q1 25 | 10.0% | 67.3% | ||
| Q4 24 | — | 26.3% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | -16.3% | 32.8% | ||
| Q1 24 | — | 57.2% |
| Q4 25 | 1.8% | 0.4% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | 3.3% | 0.8% | ||
| Q1 25 | 2.4% | 1.3% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | 3.3% | 0.7% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 4.21× | 1.42× | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | -0.16× | 0.71× | ||
| Q1 25 | 3.38× | 2.31× | ||
| Q4 24 | — | 1.09× | ||
| Q3 24 | — | 1.32× | ||
| Q2 24 | -1.54× | 1.14× | ||
| Q1 24 | — | 2.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
QLYS
| Sales Channel Through Intermediary | $88.6M | 51% |
| Sales Channel Directly To Consumer | $86.7M | 49% |
